Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PK/PD”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04448821
What this trial is testing

A Clinical Trial to Evaluate the Effect of Nilotinib on the PK/PD of Meformin

Who this might be right for
Healthy
Hyewon Chung 16
Testing effectiveness (Phase 2)Ended earlyNCT05478031
What this trial is testing

A Phase 2a Study to Investigate REM0046127 in Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
reMYND 14
Early research (Phase 1)Study completedNCT00574912
What this trial is testing

Characteristics of Glargine in Type 2 Diabetics

Who this might be right for
Type 2 Diabetes
Vanderbilt University Medical Center 20
Testing effectiveness (Phase 2)Looking for participantsNCT03708900
What this trial is testing

Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome

Who this might be right for
Cushing Syndrome
RECORDATI GROUP 12
Testing effectiveness (Phase 2)Ended earlyNCT03307512
What this trial is testing

PK and PD Profile of Dance 501 in Healthy, Non-diabetic Subjects With Mild to Moderate Asthma or COPD

Who this might be right for
Safety and Tolerability
Dance Biopharm Inc. 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT07461181
What this trial is testing

Evaluate the Safety, Tolerability, PK, PD, and Preliminary Efficacy of CS01 in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced or Metastatic Solid Tumors
Ruijin Hospital 10
Early research (Phase 1)Ended earlyNCT04045028
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Preliminary Activity of Tiragolumab in Participants With Relapsed or Refractory Multiple Myeloma or With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
Multiple MyelomaNon-Hodgkin LymphomaB-Cell Lymphoma
Genentech, Inc. 41
Early research (Phase 1)Study completedNCT01308541
What this trial is testing

Characterize Pharmacokinetics (PK) and Pharmacodynamics (PD) of LUSEDRA® Administered as Continuous Infusion or Bolus Compared With Continuous Infusion of Propofol Injectable Emulsion

Who this might be right for
Monitored Anesthesia Care
Eisai Inc. 20
Testing effectiveness (Phase 2)Ended earlyNCT06365437
What this trial is testing

A Dose Escalation Study of TCD601 Compared to ATG in de Novo Renal Transplantation

Who this might be right for
Kidney Transplantation
ITB-Med LLC 33
Early research (Phase 1)Study completedNCT01044537
What this trial is testing

A Trial To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Single Doses Of PF-04937319 In Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Pfizer 50
Early research (Phase 1)Active Not RecruitingNCT07551505
What this trial is testing

Safety, PK, and PD of BSA204 in Chinese Adults With Borderline Elevated Lipoprotein(a)

Who this might be right for
Dyslipidemias
Bisirna Therapeutics (Suzhou) Co., Ltd. 40
Early research (Phase 1)Study completedNCT05496205
What this trial is testing

A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers

Who this might be right for
OsteoarthritisPainPost Herpetic Neuralgia+3 more
iN Therapeutics Co., Ltd. 104
Early research (Phase 1)Looking for participantsNCT06946641
What this trial is testing

A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis Patients

Who this might be right for
Atopic DermatitisHidradenitis Suppurativa (HS)Rheumatoid Arthritis (RA)
Shanghai Qilu Pharmaceutical Research and Development Center LTD 102
Not applicableStudy completedNCT03438981
What this trial is testing

Optimization of PK/PD Target Attainment for Ceftriaxone in Critically Ill Patients With Community-acquired Pneumonia.

Who this might be right for
PharmacokineticsCritical Illness
Universitaire Ziekenhuizen KU Leuven 30
Testing effectiveness (Phase 2)Study completedNCT04284995
What this trial is testing

Open Label Study to Assess the PK/PD Properties of RUC-4 in Patients With a ST-elevation Myocardial Infarction

Who this might be right for
Coronary DiseaseMyocardial InfarctionHeart Diseases+2 more
CeleCor Therapeutics 27
Not applicableUnknownNCT00162877
What this trial is testing

The Role of CYP2C19 on the Eradication of H. Pylori Infection:Implication of PK/PD Relationships

Who this might be right for
Peptic Ulcer With H. Pylori InfectionGastritis With H. Pylori Infection
National Taiwan University Hospital 80
Large-scale testing (Phase 3)Looking for participantsNCT04808505
What this trial is testing

Evaluate the Safety, Efficacy, PK, PD and Immunogenicity of Cipaglucosidase Alfa/Miglustat in IOPD Subjects Aged 0 to <18

Who this might be right for
Glycogen Storage Disease Type II Infantile Onset
Amicus Therapeutics 36
Testing effectiveness (Phase 2)Study completedNCT02244541
What this trial is testing

Phase 2a Dose Finding, PK/PD and 12 Month Exploratory Efficacy Study of ANAVEX2-73 in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Anavex Life Sciences Corp. 32
Testing effectiveness (Phase 2)Study completedNCT00834041
What this trial is testing

Evaluate the Safety/Tolerability and Pharmacokinetics of Aliskiren in Hypertensive Pediatric and Adolescent Patients 6-17 Years of Age

Who this might be right for
Hypertension
Novartis 39
Early research (Phase 1)Study completedNCT00949559
What this trial is testing

Pharmacodynamics (PD) and Pharmacokinetics (PK) Study of EP-100 in Advanced Solid Tumors

Who this might be right for
Solid TumorsAdvanced Solid Tumors
Esperance Pharmaceuticals Inc 38
Next Page